AiCure tackling medication adherence with artificial intelligence [Video]

With medication adherence becoming a focal point across the industry, myriad approaches have arisen to counter the $300 billion challenge, from the relatively simple like text messaging and direct mailers to multifaceted methods that involve increasingly creative uses of technology.

One approach involving the latter is the application of artificial intelligence, and New York-based AiCure is gaining traction with its model, which involves using facial recognition and motion-sensing technologies through mobile devices.

The company, started in 2010, recently received recognition in the form of  $3.4 million in grants from the National Institutes of Health to expand its model. Initially, AiCure carved itself a unique niche within medication adherence by tackling the problem in clinical trials, itself about a $15 billion problem for pharmaceutical companies with often unreliable patients. That, in turn, drags out the process and drives up the cost, according to AiCure CEO Adam Hanina.

“The problem is if you don’t know the patients are taking the medication, you don’t k …